ライフサイエンスコーパス: design

1 In a design using basic features of revealed preference theory, we

2 anding of the role of ionic correlations in NP assembly and design rules to utilize the salting-out process to crystalliz

3 opportunities and challenges in RNA structural modeling and design, as recently discussed during the second Telluride Sci

4 ly approved inhibitors of MBLs are currently unavailable as design has been limited by the incomplete knowledge of their

5 a peculiar to nanoconfined water paves the way for a better design of nanoporous materials for energy applications; for i

6 There was a graded association also in the cosibling design comparing siblings with varying degree of discordance

7 MRI) in a 2-drug, double-blind placebo-controlled crossover design conducted from January 21, 2009, to September 29, 2011

8 implications that this may have for bioinformatics database design.

9 utical development, and nucleic acid based biosensor device design.

10 n electron donor has been exploited in knowledge-based drug design.

11 the implications of GPCR conformational plasticity for drug design.

12 will be an important asset in future anti-inflammatory drug design.

13 t responses will enable novel routes for PTP-selective drug design, important for managing diseases such as cancer and Al

14 by adjusting the applied voltage or changing the electrode design.

15 ase using an event-related functional MRI (fMRI) experiment design.

16 Furthermore, we discuss key experimental design considerations, including the choice of the method use

17 in a functionally relevant context using a fully factorial design.

18 mized control trial, 3 groupsx4 time points mixed factorial design conducted from July 2015 to March 2016.

19 ulation in denitrification, which may contribute to further design strategies to control greenhouse gas emissions from ag

20 We here employ computational and structure-guided design to develop improved native-like trimers that reduce ex

21 henylbenzamides, providing a new structural lead for ligand design.

22 This Communication describes a new molecular design that yields ultranarrowband organic photodetectors.

23 Therefore, the new design allows a 30-fold longer reaction time and a 40-fold in

24 Our design approach opens new avenues for optically controlling e

25 Strengths include large sample size, prospective design, and virtually complete follow-up; however, histologic

26 Through a rational design approach we discovered a highly selective and potent B

27 harmaceutical properties is usually carried out by rational design and/or directed evolution.

28 evelop during natural infection can help guide the rational design of an HIV vaccine.

29 CEBS data collection component is an integrated relational design that allows the flexibility to capture any type of ele

30 Using a split half-sibling design, we exposed embryos of 10 families from each of two po

31 ctrocatalysts is challenging and entails material structure design and tailoring across a range of length scales.

32 These obstacles can be overcome with thoughtful study design to ensure maximal risk mitigation.

33 nature of the nanophotonic system significantly alters the design criteria for the necessary conducting front electrode.

34 In this work, we discuss the design and synthesis of the DiPyrO tag, characterize its effe

35 nly in relation to cucurbituril chemistry, but also for the design of novel supramolecular architectures.

36 Current 2D bioelectronics research is focused on the design of simple-to-use and cheaper biodevices, while improvi

37 We report the design and application of single-chain cofactor-free kinases

38 In this study, we report the design and synthesis of a series of diarylureas derived from

39 Here, we report the design of a set of living materials and devices based on stre

40 Herein is reported the design and application of a reagent for the direct functional

41 s a footprint of only 3.8 x 2.5 mum, and is well within the design rules of a typical silicon photonics process, with a m

42 above-mentioned disorders and to help medicinal chemists to design novel dynamin ligands, which could be useful in the tr

43 parameters, such as stirring rate, that may be exploited to design other quasicrystal-forming self-assembly chemistries a

44 and metal stress in bacteria could be a useful strategy to design new approaches to antibacterial therapy.

45 on that is characteristic of D. hamiltonii could be used to design specific assays, enhancing its applicability for direc

46 Although clinical trial design is challenging, due in part to a lack of robust biomar

47 ntegration of patient and caregiver perspectives into trial design.

48 Structure-based vaccine design depends on extensive structural analyses of antigen-an

49 proteins may be a potential mechanism of universal vaccine design.

50 Additionally, we design and compare the performance of networks with N-stable